Skip to main content
. Author manuscript; available in PMC: 2024 Mar 15.
Published in final edited form as: Vaccine. 2023 Mar 10;41(15):2572–2581. doi: 10.1016/j.vaccine.2023.03.008

Table 3.

Early-season influenza vaccination coveragea among adults aged ≥ 18 years by influenza vaccination hesitancy beliefs, United States—National Internet Flu Survey, 2018.

Unadjusted Coverage (95% CI) Adjusted Coverageb (95% CI) Adjusted Prevalence Differenceb (95% CI)
Overall, how hesitant are you about influenza vaccinations?
Somewhat/very hesitant 15.3 (13.2, 17.6) 16.6 (14.2, 18.9) −45.2 (−48.5, −41.8)
Not that/not at all hesitant 62.4 (60.1, 64.6) 61.8 (59.4, 64.1) Referent
Did concerns about serious, long-term side effects impact your decision to get an influenza vaccination?
Yes 26.5 (23.1, 30.3) 26.8 (23.1, 30.5) −22.9 (−27.1, −18.7)
No 49.1 (47.2, 51.1) 49.7 (47.7, 51.7) Referent
Do you personally know anyone who has had a serious, long-term side effect from an influenza vaccination?
Yes 29.9 (25.6, 34.6) 31.0 (26.4, 35.6) −16.7 (−21.6, −11.7)
No 47.5 (45.6, 49.4) 47.7 (45.7, 49.6) Referent
Is your doctor or health provider your most trusted source of information about influenza vaccinations?
Yes 52.8 (50.6, 55.0) 50.4 (48.2, 52.7) Referent
No 30.5 (27.7, 33.4) 35.1 (32.1, 38.1) −15.3 (−19.1, −11.5)

Note: Boldface indicates statistical significance compared to reference group using t-test (p < 0.05).

a

Separate multivariable logistic regression models were run for each influenza vaccination hesitancy question for a total of four individual models. The outcome variable is receipt of early-season influenza vaccination by mid-November 2018.

b

The model adjusted for sex, age, race/ethnicity, marital status, education level, employment status, annual household income, having a usual place to go when sick, had high-risk conditions for influenza complications, having health insurance, and metropolitan statistical area status.